flow trial semaglutide kidney outcomes 2024 results FLOWing with the — NephJC Diabetes Distilled: Keeping kidneys FLOWing

In fact

Available drugs produced, on average, about 5% body weight reduction meaningful for metabolic health, but nowhere near what patients hoped for

Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead

Instead, true appetitive suppressants are medically prescribed and closely supervised by your doctor

ahin S, Yldrm M, Bekta , et al